Analgesics⏵
Antiandrogens⏵
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle⏵
Melatonin
Metformin
Minerals⏵
Molnupiravir
Monoclonals⏵
Naso/orophar..⏵
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins⏵
More⏵

Other
Feedback
Home
Top
Results
All zinc studies
Meta analysis
 
Feedback
Home
←
next
study
→
previous
study
c19early.org COVID-19 treatment researchZincZinc (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta
Home Adoption Other Treatments
@CovidAnalysis
All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Oxygen therapy 86% Improvement Relative Risk Zinc for COVID-19  Fujita et al.  Sufficiency Are zinc levels associated with COVID-19 outcomes? Retrospective study in Japan (March 2020 - April 2021) Lower need for oxygen therapy with higher zinc levels (p=0.0074) c19early.org Fujita et al., J. Infection and Chemot.., Mar 2024 Favors zinc Favors control

Zinc deficiency is a potential risk factor for COVID-19 progression to pneumonia requiring oxygen therapy

Fujita et al., Journal of Infection and Chemotherapy, doi:10.1016/j.jiac.2024.03.007
Mar 2024  
  Post
  Facebook
Share
  Source   PDF   All   Meta
Zinc for COVID-19
2nd treatment shown to reduce risk in July 2020
 
*, now known with p = 0.0000013 from 44 studies, recognized in 11 countries.
Lower risk for mortality, ventilation, hospitalization, progression, recovery, and viral clearance.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,100+ studies for 60+ treatments. c19early.org
Retrospective 60 hospitalized COVID-19 patients in Japan showing higher risk of progression to pneumonia requiring oxygen therapy with zinc deficiency at the time of diagnosis.
Important missing comments or errors? Let us know.
risk of oxygen therapy, 86.3% lower, OR 0.14, p = 0.007, cutoff 60μg/dL, adjusted per study, inverted to make OR<1 favor high zinc levels (≥60μg/dL), multivariable, RR approximated with OR.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Fujita et al., 8 Mar 2024, retrospective, Japan, peer-reviewed, 6 authors, study period 31 March, 2020 - 30 April, 2021.
This PaperZincAll
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0